Stocks › AI medical concept stocks › TDOC

Teladoc Health TDOC

US equityMarket cap rank #3234AI medical concept stocks

$5.56 −$0.21 (-3.64%)

Pre-market · Oct 8, 8:20 am ET · After hours $5.56 0.00%

Open$5.76

Prev close$5.77

Day range$5.53 – $5.76

Volume3.62M

Market cap$1.01B

P/E (TTM)–

Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership84.7%+0.05 pts vs. prior quarter

Institutions holding413+0 vs. prior quarter

Insider trades (recent)17 buys / 33 sellsNet selling

Short interest15.21% of floatDays to cover 8.5 · as of 15 Sep 2026

Short-sale volume share25.2%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$1.23M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 29.9% of shares outstanding.

Largest holders

BlackRock8.93%
Vanguard Portfolio Management, LLC6.98%
Vanguard Capital Management, LLC5.04%
Point72 Asset Management, L.P.4.54%
Renaissance Technologies Corp.4.44%
Voss Capital, LP4.43%
Dimensional Fund Advisors4.06%
State Street Global Advisors2.73%

By investor type

Mutual Fund59.59%
Hedge Fund17.95%
Public Company3.12%
Private Company2.10%
VC/PE Fund1.10%
Individual/Insider0.69%
Government Pension Fund0.40%
Insurance Company0.26%

Reported short interest has held roughly steady near 15.21% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

Holder	Type	Period	Share change	New stake
Barrow, Hanley, Mewhinney & Strauss, LLC	Mutual Fund	2026/Q3	+286,073	0.2%
Voss Capital, LP	Hedge Fund	2026/Q3	+3,846,679	4.4%
Arrowstreet Capital, Limited Partnership	Mutual Fund	2026/Q3	+2,040,051	1.1%
BlackRock	Mutual Fund	2026/Q3	+1,609,578	8.9%
Acadian Asset Management LLC	Mutual Fund	2026/Q3	+1,484,287	1.0%
American Century Investment Management	Mutual Fund	2026/Q3	+1,438,120	2.7%
The Goldman Sachs Group, Inc.	Public Company	2026/Q3	+1,100,066	1.7%
Dimensional Fund Advisors	Mutual Fund	2026/Q3	+1,073,294	4.1%
Union Square Park Capital Management, LLC	Hedge Fund	2026/Q3	+800,000	0.4%
FMR	Mutual Fund	2026/Q3	+729,757	0.4%
AQR Capital Management	Hedge Fund	2026/Q3	+715,801	0.9%
Allspring Global Investments, LLC	Mutual Fund	2026/Q3	+715,073	0.5%
State Street Global Advisors	Mutual Fund	2026/Q3	+602,631	2.7%
Franklin Resources	Mutual Fund	2026/Q3	+518,967	0.6%
Point72 Asset Management, L.P.	Hedge Fund	2026/Q3	+518,432	4.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

Date	Insider	Title	Transaction	Shares	Price	Held after
1 Oct 2026	Joseph Catapano	Chief Accounting Officer	Derivative Exercise and Sale	-655	$5.65	14,293
30 Sep 2026	Joseph Catapano	Chief Accounting Officer	Derivative Exercise and Retained	+1,428	–	14,293
10 Sep 2026	Charles Divita	Chief Executive Officer	Intent to Sell (Form 144)	-17,805	$6.10	–
10 Sep 2026	Charles Divita	Chief Executive Officer	Derivative Exercise and Sale	-17,805	$6.10	465,535
9 Sep 2026	Charles Divita	Chief Executive Officer	Derivative Exercise and Retained	+24,997	–	465,535
2 Sep 2026	Fernando Madeira	President of BetterHelp	Intent to Sell (Form 144)	-9,812	$6.51	–
2 Sep 2026	Fernando Madeira	President of BetterHelp	Derivative Exercise and Sale	-15,251	$6.51	–
1 Sep 2026	Charles Divita	Chief Executive Officer	Intent to Sell (Form 144)	-18,327	$6.30	–
1 Sep 2026	Adam Vandervoort	Chief Legal Officer	Intent to Sell (Form 144)	-7,573	$6.30	–
1 Sep 2026	Fernando Madeira	President of BetterHelp	Intent to Sell (Form 144)	-5,439	$6.30	–
1 Sep 2026	Kelly Bliss	President of U.S. Group Health	Intent to Sell (Form 144)	-7,357	$6.30	–
1 Sep 2026	Carlos Nueno	President of International	Intent to Sell (Form 144)	-6,200	$6.30	–
1 Sep 2026	Charles Divita	Chief Executive Officer	Derivative Exercise and Sale	-18,327	$6.30	440,538
1 Sep 2026	Joseph Catapano	Chief Accounting Officer	Derivative Exercise and Sale	-274	$6.30	12,865
1 Sep 2026	Adam Vandervoort	Chief Legal Officer	Derivative Exercise and Sale	-7,573	$6.30	117,616
1 Sep 2026	Kelly Bliss	President of U.S. Group Health	Derivative Exercise and Sale	-7,357	$6.30	92,832
1 Sep 2026	Carlos Nueno	President of International	Derivative Exercise and Sale	-6,200	$6.30	64,744
31 Aug 2026	Charles Divita	Chief Executive Officer	Derivative Exercise and Retained	+25,916	–	440,538
31 Aug 2026	Joseph Catapano	Chief Accounting Officer	Derivative Exercise and Retained	+598	–	12,865
31 Aug 2026	Michael Grasher	Chief Financial Officer	Other Derivative Acquisition	+239,616	–	239,616

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Sep 2026	27,626,898	15.2%	8.5
31 Aug 2026	25,341,412	13.9%	7.2
14 Aug 2026	23,688,368	13.0%	5.0
31 Jul 2026	26,303,828	14.5%	4.0
15 Jul 2026	28,060,519	15.5%	6.6
30 Jun 2026	27,420,966	15.2%	5.7

Discussion

No comments yet — be the first to weigh in on TDOC.